Differential SLC1A2 Promoter Methylation in Bipolar Disorder With or Without Addiction
Yun‐Fang Jia(Mayo Clinic), Marin Veldić(WinnMed), Mark A. Frye(Mayo Clinic), Joanna M. Biernacka, Jennifer R. Geske(Mayo Clinic in Florida), Susan L. McElroy(Southwestern Medical Center), YuBin Choi(Mayo Clinic), Daniel R. Lindberg(Mayo Clinic), Doo‐Sup Choi(Mayo Clinic), Jennifer Ayers-Ringler(Mayo Clinic)
Cited by 42
Related Papers
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754
Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders
|Nature Neuroscience|2018|718
Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
|PLoS Genetics|2012|543
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
|Journal of Clinical Oncology|2008|377